InvestSMART

Cochlear Limited (ASX: COH) - ETF Exposure

Current share price for COH : $129.040 0.46 (0.36%)+

Cochlear Limited (COH) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It has been the global leader in implantable hearing solutions for over 40 years, providing a range of implants and sound processor upgrades that deliver a lifetime of hearing outcomes.

COH General Information +

ASX Code COH
Website http://www.cochlear.com
Industry/Sector Health Care Equipment
Market Cap ($M) 8,439
COH Share Price $129.040
Day High $130.960
Day Low $128.720
Last Close $129.500
COH Share Price Movement $0.46 ( 0.36% )
Prices as at 11:25, 8 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to COH

As a significant Australian company by market capitalisation, COH is held across 39 ETFs spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when COH moves, funds like MVE, AQLT, IMPQ, FAIR and ALFA that hold it can move with it.

For more concentrated exposure, ETFs such as MVE (VanEck S&P/ASX MidCap ETF) allocate about 2.7% to COH , while the average exposure across all 39 ETFs that hold it is around 0.8% .

Top ETF holdings

Last updated: ETF data and holdings as at 7 October 2026

Own COH directly or through an ETF?

How does holding Cochlear Limited (COH) shares directly compare to ETFs that include it?

COH Direct
MVE
ASX 		AQLT
ASX 		IMPQ
ASX 		FAIR
ASX 		ALFA
ASX
Holdings 1 company 53 holdings 46 holdings 41 holdings 83 holdings 105 holdings
COH Weight 100% 2.7% 2.6% 2% 1.8% 1.6%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.45% p.a. 0.35% p.a. - 0.49% p.a. 0.39% p.a.
Approx. Yield 2.8% 2.68% 4.13% - 3.18% 0.87%
Star Ratings - starstarstarstar starstarstarstar Not Rated starstarstarstar star

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not COH's direct yield. Annual cost uses each ETF's MER.

COH Exposure on $10,000 investment

How a $10,000 investment in Cochlear Limited (COH) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Cochlear Limited (COH) Direct share $129.040 -7.56% -$756 $9,244
VanEck S&P/ASX MidCap ETF (MVE) Equity - Australia Small/Mid Cap $43.310 -1.77% -$177 $9,823
BetaShares Australian Quality ETF (AQLT) Equity - Australia Strategy $34.850 -0.97% -$97 $9,903
eInvest Better Future (Managed Fund) (IMPQ) - $3.980 -1% -$100 $9,900
BetaShares Australian Sustainability Leaders ETF (FAIR) Equity - Australia Strategy $18.210 -1.62% -$162 $9,838
Vaneck Australian Long Short Complex ETF (ALFA) Equity - Australia Strategy $22.965 -0.50% -$50 $9,950

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Cochlear Limited (COH) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult $1.30 85% 21 Sep 2026 14 Oct 2026 - - -
Result $2.15 85% 19 Mar 2026 13 Apr 2026 - - -
HFResult $2.15 85% 18 Sep 2025 13 Oct 2025 - - -

See all dividends from Cochlear Limited (COH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cochlear Limited (COH) price-sensitive announcements

COH - FY26 Result - Presentation
Cochlear Limited reported a 2% increase in constant currency sales revenue for FY26, achie
Cochlear Limited (COH)
18 Aug 2026 | 7:50 AM
COH - FY26 Result - ASX & Media Release
Cochlear Limited's FY26 results showed an underlying net profit of $322 million, with chal
Cochlear Limited (COH)
18 Aug 2026 | 7:30 AM
COH - Appendix 4E
The preliminary final report for Cochlear Limited as of 30 June 2026 shows a slight decrea
Cochlear Limited (COH)
18 Aug 2026 | 7:30 AM
COH - Trading update and reduction to FY26 earnings guidance
Cochlear Limited has issued a trading update and revised its FY26 earnings guidance downwa
Cochlear Limited (COH)
22 Apr 2026 | 8:20 AM

Cochlear Limited (COH) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,439 Change in substantial holding 6 Oct 2026 8:18AM $130.660 $129.040 fallen by 1.24%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,439 Defence of Class Action Proceedings 29 Sep 2026 8:21AM $145.130 $129.040 fallen by 11.09%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,439 Cochlear to host Capital Markets Day 25 Sep 2026 8:31AM $142.800 $129.040 fallen by 9.64%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,439 Notification regarding unquoted securities - COH 24 Sep 2026 8:23AM $140.690 $129.040 fallen by 8.28%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,439 Update - Dividend/Distribution - COH 23 Sep 2026 9:06AM $141.080 $129.040 fallen by 8.53%
Cochlear Limited (COH)
ORDINARY FULLY PAID
 Health Care $8,439 Notice of Annual General Meeting & Proxy/Voting Form 22 Sep 2026 3:43PM $140.175 $129.040 fallen by 7.94%

COH Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $462.53 $701.75 10.90% 43.96 490.00 1.59% 100.0%
2025F $417.22 $633.00 7.60% 48.74 440.00 1.43% 100.0%
2024A $386.60 $588.25 27.00% 48.98 410.00 1.42% 75.1%

COH Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Cochlear Limited (COH) $8,519M -0.3136 0.2540 0.0785 31.7127 25.2893 23.4487 2.65% 2.75% 2.99%
Fisher & Paykel Healthcare Corporation Limited (FPH) $21,960M 0.1388 0.1452 0.1574 56.4494 49.2935 42.5898 1.16% 1.25% 1.40%
Imricor Medical Systems Inc (IMR) $531M -0.4254 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed Inc. (RMD) $18,244M 9.5922 0.0986 0.0915 20.7779 18.9136 17.3282 1.12% 1.22% 1.31%

COH Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.93 29.50 4.87 1.81
Market 0.64 15.40 1.61 1.24
Sector 0.72 21.20 2.15 2.46

COH Directors

Name Position Start Date
Ms Christine Frances McLoughlin Non-Executive Director 1 Nov 2020
Sir Michael Grenfell Daniell Non-Executive Director 1 Jan 2020
Ms Karen Lee Collett Penrose Non-Executive Director 1 Jul 2022
Mr Richard John Freudenstein Non-Executive Director 25 Aug 2025
Professor Bruce Gregory Robinson AC Non-Executive Director 13 Dec 2016
Mr Michael del Prado Non-Executive Director 1 Jan 2022
Ms Caroline Louise Clarke Non-Executive Director 2 Sep 2024
Ms Catriona Alison Deans Non-Executive Director, Non-Executive Chairman 1 Jan 2015
Mr Dig Howitt President, Chief Executive Officer, Managing Director 14 Nov 2017

Cochlear Limited (COH) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
1 Sep 2026 FREUDENSTEIN, Richard Buy Indirect Shares 1,100 $135.480 $149,028.000
24 Aug 2026 DEL PRADO, Michael Buy Direct Shares 412 $96.750 $39,861.000
24 Aug 2026 CLARKE, Caroline Buy Direct Shares 257 $136.000 $34,952.000

See all changes in directors' interest & trades for Cochlear Limited (COH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

COH Management

Name Position
Sarah Thom CFO
Jan Janssen Chief Technology Officer
Kristy Jo Company Secretary
Rob McGrory Company Secretary

COH Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Cochlear Limited (COH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
4,692,142 (7.20%) State Street Corporation and subsidiaries
4,352,496 (6.70%) BlackRock, Inc
3,854,464 (5.90%) The Vanguard Group,Inc

COH Calendar of Events

Date Event
17 August 2027 Report (Annual)
17 August 2027 Report (Prelim)
12 February 2027 Report (Interim)
14 October 2026 Div Pay Date

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.